Liver disease

Liver disease background banner.
Liver disease background banner.
Liver disease background banner.

The liver is the largest internal organ in the body and hepatic function is crucial to good health. A variety of analytes are designated as routine markers of liver disease. When used together in panels or individually, they can help detect and monitor hepatic disease.

For in vitro diagnostics use.

Abbott's liver function assays are designed to help evaluate liver health. Albumin is the major blood protein and is produced by the liver. Two dye binding assays, BCG and BCP, are used to measure albumin, which is decreased or increased in various diseases. The common liver enzymes ALT and AST are important markers for conditions such as hepatitis.

Hepatic malfunction is indicated by abnormal levels of direct and total bilirubin. Ammonia is a marker of acute liver failure and the enzyme GGT is associated with alcohol abuse and liver cirrhosis.  Bile acids produced by the liver are necessary to lipid metabolism.  All of these can be used to narrow and accurately assess disease states and treatment options. 



Core Laboratory Menu and Systems

View and download the Core Laboratory menus to see the complete list of available assays and in development assays, categorized by instrument.

Some assays may not be available on all platforms or in all regions.


Liver Disease
Albumin (BCG)
Albumin (BCP)
Alkaline Phosphatase
Alpha-1 Antitrypsin
ALT (Alanine Aminotransferase)
ALT, Activated (Alanine Aminotransferase)
AST (Aspartate Aminotransferase)
AST, Activated (Aspartate Aminotransferase)
Bile Acids
Direct Bilirubin
GGT (Gamma-Glutamyl Transferase)
Lactate Dehydrogenase (LD)
Total Bilirubin


Anti-HBc IgM
Anti-HBc II
HBeAg (Quantitative)
HBeAg Qualitative/Quantitative
HBsAg (Quantitative)
HBsAg (Quantitative) Confirmatory
HBsAg Next Confirmatory
HBsAg Next Qualitative
HBsAg Qualitative II
HBsAg Qualitative II Confirmatory

Committed to the hepatitis in vitro diagnostics community for over 50 years

Scientists at Abbott and market experts are continuously working together to solve today's challenges, understand future needs and eliminate gaps in the diagnosis of hepatitis infected patients and in our overall health care community. Abbott continues to research and invest in expanding hepatitis-testing options to a variety of diagnostic platforms.

Hepatitis panel
Hepatitis panel
Hepatitis panel

Knowledge Center

Find the latest information in laboratory science, therapeutic areas and Abbott innovation.

Customer Portal

Receive exclusive benefits and resources when you register to access to the Customer Portal.

Contact Us

Abbott's Representatives are ready to offer support, gather feedback, and answer any questions.